Press releases | Finanzwire

PRESS RELEASE

published on 07/30/2025 at 14:30, 11 months 9 days ago

Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
NanoViricides introduces drug candidate NV-387 as a potential treatment for Measles outbreak. The drug has shown safety and effectiveness in animal studies and Phase I trial, aiming to combat the global epidemic

NanoViricides NV-387 Antiviral Vaccination Measles
PRESS RELEASE

published on 07/30/2025 at 14:29, 11 months 9 days ago

INSIDE INFORMATION / OTHER NEWS RELEASES
Medincell's partner Teva Pharmaceuticals raises 2025 revenue outlook for UZEDY® to $190–$200M and confirms Olanzapine LAI on track for submission in 2025

Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI Submission
PRESS RELEASE

published on 07/30/2025 at 14:25, 11 months 9 days ago

Forward Water Technologies Announces Financial Results for the Fifteen-Month Period Ended March 31, 2025
Forward Water Technologies Corp. (FWTC) releases financial results for the fifteen-month period ended March 31, 2025. CEO discusses successful trial with iFO™ process and plans for technology expansion

Financial Results Forward Water Technologies Corp. Technology Expansion IFO™ Process Publicly Traded
PRESS RELEASE

published on 07/30/2025 at 14:00, 11 months 9 days ago

GameSquare's Stream Hatchet Publishes 2025 Q2 Live Streaming Trends Report
Global live streaming viewership grew 5% YoY to 9.1 billion hours in Q2 2025, reaching highest level since 2021, as per Stream Hatchet report by GameSquare Holdings

GameSquare Holdings Stream Hatchet Live Streaming Viewership Q2 2025
PRESS RELEASE

published on 07/30/2025 at 14:00, 11 months 9 days ago

Stabilis Solutions Announces Second Quarter 2025 Conference Call and Webcast Date
Stabilis Solutions, Inc. to issue Q2 2025 results on August 6, 2025, with a conference call on August 7, 2025, to discuss financial results and recent events

Financial Results Conference Call Investor Relations Stabilis Solutions Q2 2025 Results
PRESS RELEASE

published on 07/30/2025 at 14:00, 11 months 9 days ago

Nextech3D.AI Reports Audited Financial Results; 55% Gross Profit Growth and 58% Reduction in Operating Cash Burn
Nextech3D.AI Corp. announces improved financial results for the 15-month period ended March 31, 2025, showing increased gross profit, margin, and operational efficiencies. CEO Gappelberg highlights margin expansion and recurring revenue growth strategy

Financial Results Nextech3D.ai Recurring Revenue AI-powered Solutions Margin Expansion
PRESS RELEASE

published on 07/30/2025 at 14:00, 11 months 9 days ago

EonX Signs Partnership with PartsCheck to Launch Automotive Industry Payments & Loyalty Solution
EonX Technologies Inc. partners with PartsCheck to launch 'PartsPay', an innovative payments solution rewarding business customers with points in the automotive industry. The agreement aims to redefine transactions and create value in the supply chain

Automotive Industry Loyalty Program EonX Technologies Inc. PartsCheck Payments Solution
PRESS RELEASE

published on 07/30/2025 at 13:42, 11 months 10 days ago

Inside Information / Other news releases
Medincell's partner Teva increases 2025 revenue outlook for UZEDY® to $190–$200M, plans olanzapine LAI submission. Company's innovative treatments aim to improve medicine accessibility

Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
PRESS RELEASE

published on 07/30/2025 at 13:30, 11 months 10 days ago

Salzgitter AG sells DESMA Schuhmaschinen GmbH to NAME & MAWI Partners S.A.S.
Salzgitter AG sells DESMA Schuhmaschinen GmbH to NAME & MAWI Partners S.A.S., furthering portfolio management strategy. Transaction to be completed in autumn 2025

Acquisition Portfolio Management Salzgitter AG DESMA Schuhmaschinen GmbH NMP Group
PRESS RELEASE

published on 07/30/2025 at 13:30, 11 months 10 days ago

MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
MIRA Pharmaceuticals announces new preclinical data showing topical Ketamir-2 provides effective pain relief comparable to injected morphine in animal models. The treatment has potential for both centralized and localized pain pathways

Preclinical Data MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain Topical Pain Relief

Published on 07/09/2026 at 13:35, 17 minutes ago

Silver X Delivers Record Quarterly Production During the Second Quarter of 2026
Published on 07/09/2026 at 13:30, 22 minutes ago

Stillwater Critical Minerals Expands 2026 Exploration Program and Provides Project Update
Published on 07/09/2026 at 13:00, 52 minutes ago

Evergold Mobilizes Drill to Golden Lion and Completes MobileMT Airborne Geophysical Survey, Toodoggone District, Northern BC
Published on 07/09/2026 at 13:00, 52 minutes ago

Jaguar Mining Reports Commencement of Directional Drilling Program at Pilar Gold Mine, Minas Gerais, Brazil
Published on 07/09/2026 at 13:00, 52 minutes ago

ATHA Energy Reports Widest Intersection to Date at Rib North Discovery with 37 m of Composite Uranium Mineralization in Ribn-DD-003 – Multiple Drillholes Demonstrating Continuity of Uranium Mineralization

View all ACCESSWIRE

Published on 07/09/2026 at 12:35, 1 hour 17 minutes ago

Cognizant to scale to 5,000 Frontier Certified Engineers and 10,000 Frontier Business Operators
Published on 07/09/2026 at 12:34, 1 hour 18 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 07/09/2026 at 12:30, 1 hour 22 minutes ago

Immunic to Participate in Investor Conferences in July
Published on 07/09/2026 at 12:16, 1 hour 36 minutes ago

Phase III GRAPPA trial supports ATLG (Grafalon®) as standard of care in matched unrelated donor stem cell transplantation
Published on 07/09/2026 at 11:57, 1 hour 55 minutes ago

Director/PDMR Shareholding

View all EQS

Published on 07/09/2026 at 07:30, 6 hours 22 minutes ago

Half-year liquidity contract statement June 30, 2026
Published on 07/09/2026 at 07:30, 6 hours 22 minutes ago

Half-year liquidity contract statement June 30, 2026
Published on 07/08/2026 at 18:30, 19 hours 22 minutes ago

Suspension of the liquidity contract
Published on 07/08/2026 at 18:00, 19 hours 52 minutes ago

€464 MILLION OF NEW FINANCING TO SUPPORT FREY'S GROWTH
Published on 07/08/2026 at 17:45, 20 hours 7 minutes ago

Half-year liquidity contract statement of ALTEN SA as at 30 June 2026

View all LES ECHOS COMFI WIRE

News